HNF1 alpha gene coding regions mutations screening, in a Caucasian population clinically characterized as MODY from Argentina

Diabetes Research and Clinical Practice

Volumn 91, Issue 2, 2011, Pages 208-212

  Lopez, Ariel Pablo ^a   Foscaldi, Sabrina Andrea ^a   Perez, Maria Silvia ^a   Rodriguez, Martín ^b   Traversa, Mercedes ^a   Puchulu, Félix Miguel ^a   Bergada, Ignacio ^c   Frechtel, Gustavo Daniel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Diabetes; HNF1 alpha; MODY 3; Mutation

Indexed keywords

ADOLESCENT; ARGENTINA; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HNF1A GENE; HUMAN; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS 3; PREVALENCE;

ADOLESCENT; ADULT; ARGENTINA; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MUTATION; YOUNG ADULT;

EID: 79952042550     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.11.024     Document Type: Article

References (30)

1. American Diabetes Association (A.D.A.) Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31(Suppl. 1):S55-S60.
2. MIM #606391; Maturity Onset Diabetes of the Young; MODY; http://www.ncbi.nlm.nih.gov/omim/606391.
3. Yamada S., Nishigori H., Onda H., Utsugi T., Yanagawa T., Maruyama T., et al. Identification of mutations in the hepatocyte nuclear factor (HNF)-1 alpha gene in Japanese subjects with IDDM. Diabetes 1997, 46(October (10)):1643-1647.
4. Froguel P., Zouali H., Vionnet N., Velho G., Vaxillaire M., Sun F., et al. Familial Hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 1993, 328:697-702.
5. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303:1378-1381.
6. Ladias J.A., Hadzopoulou-Cladaras M., Kardassis D., Cardot P., Cheng J., Zannis V., et al. Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem 1992, 267:15849-15860.
7. Evans J.R., Kelly D.L., Morris K.J., Arvide E.M., Harris A. RNA interference-mediated inhibition of hepatocyte nuclear factor 1 alpha identifies target genes. Biochim Biophys Acta 2008, 1779(5):341-346. [Epub 2008 March 19].
8. Urhammer S.A., Fridberg M., Hansen T., Rasmussen S.K., Møller A.M., Clausen J.O., et al. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 1997, 46:912-916.
9. Holmkvist J., Cervin C., Lyssenko V., Winckler W., Anevski D., Cilio C., et al. Common variants in HNF-1a and risk of type 2 diabetes. Diabetologia 2006, 49:2882-2891.
10. Holmkvist J., Almgren P., Lyssenko V., Lindgren C.M., Eriksson K.F., Isomaa B., et al. Common variants in maturity-onset diabetes of the young genes and future risk of type 2 diabetes. Diabetes 2008, June (57)(6):1738-1744. [Epub 2008 March 10].
11. Kaisaki P.J., Menzel S., Lindner T., Oda N., Rjasanowski I., Sahm J., et al. Mutations in the hepatocyte nuclear factor 1 alpha gene in MODY and early onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 1997, 46:528-535.
12. Pearson E.R., Starkey B.J., Powell R.J., Gribble F.M., Clark P.M., Hattersley A.T. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003, 362:1275-1281.
13. Shepherd M., Pearson E.R., Houghton J., Salt G., Ellard S., Hattersley A.T. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 2003, 26:3191-3192.
14. Lopez A.P., Foscaldi S.A., Pérez M.S., Krochik G., Rodríguez M., Traversa M., et al. Glucokinase gene mutation screening in Argentinean clinically characterized MODY patients. Exp Clin Endocrinol Diabetes 2009, 117(September (8)):391-394.
15. Ellard S., Bellanné-Chantelot C. Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008, 51:546-553.
16. Yamada S., Tomura H., Nishigori H., Sho K., Mabe H., Iwatani N., et al. Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes 1999, 48:645-648.
17. Vaxillaire M., Rouard M., Yamagata K., Oda N., Kaisaki P.J., Boriraj V.V., et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 1997 6, (April (4)):583-586.
18. H.G.M.D. [human genome mutation database] http://www.hgmd.cf.ac.uk/ac/index.php.
19. Møller A.M., Dalgaard L.T., Pociot F., Nerup J., Hansen T., Pedersen O. Mutations in the hepatocyte nuclear factor 1 alpha gene in Caucasian families originally classified as having type I diabetes. Diabetologia 1998, 41:1528-1531.
20. Frayling T.M., Lindgren C.M., Chevre J.C., Menzel S., Wishart M., Benmezroua, et al. A genome-wide scan in families with maturity-onset diabetes of the young. Diabetes 2003, 52:872-881.
21. Kim S.H., Ma X., Weremowicz S., Ercolino T., Powers C., Mlynarski W., et al. Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes 2004, 53:1375-1384.
22. Ellard S., Thomas K., Edghill E.L., Owens M., Ambye L., Cropper J., et al. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia 2007, 50:2313-2317.
23. Toaima D., Näke A., Wendenburg J., Praedicow K., Rohayem J., Engel K., et al. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY). Hum Mutat 2005, 25(5):503-504.
24. Barrio R., Bellanné-Chantelot C., Moreno J.C., Morel V., Calle H., Alonso M., et al. Nine novel mutations in Maturity Onset Diabetes of the Young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002, 87(6):2532-2539.
25. Gragnoli C., Cockburn B.N., Chiaramonte F., Gorini A., Marietti G., Marozzi G., et al. Early Onset Type II Diabetes Mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase. Diabetologia 2001, 44(October (10)):1326-1329.
26. Costa A., Bescós M., Velho G., Chêvre J., Vidal J., Sesmilo G., et al. Genetic and Clinical characterisation of maturity-onset diabetes of the young in Spanish families. Eur J Endocrinol 2000, 142:380-386.
27. Domínguez-López A., Miliar-García A., Segura-Kato Y.X., Riba L., Esparza-López J., Ramírez-Jiménez S., et al. Mutations in MODY Genes Are not Common Cause of Early-Onset Type 2 Diabetes in Mexican Families. JOP. J Pancreas 2005, 6(3):238-245. [Online].
28. Moises S.R., Reis A.F., Morel V. Prevalence of Maturity-onset diabetes of the young mutations in Brazilian families with autosomal dominant early-onset type 2 diabetes. Diabetes Care 2001, 24:786-787. [PMID 11315851].
29. Tripathi B.K., Srivastava A.K. Diabetes mellitus: complications and therapeutics. Med Sci Monit 2006, 12(7):RA130-RA147.
30. Tsakiris D., Ioannou K. An underdiagnosed type of Diabetes: the MODY syndromes, Pathophysiology, clinical presentation and renal disease progression. J Nephrol 2004, 17(September-October (5)):637-641.